Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 281-013-0 | CAS number: 83833-37-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 06 to May 02, 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 1992
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 1992
- Deviations:
- yes
- Remarks:
- In the Intradermal induction of the main study the vehicle is mixed with FCA only. A mixture of FCA:physiological saline was chosen instead of FCA only in order to decrease the site effects of FCA when applied alone.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A LLNA study has not been conducted because adequate data from guinea pig Maximisation test study are already available.
Test material
- Reference substance name:
- Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]-, disodium
- EC Number:
- 281-013-0
- EC Name:
- Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]-, disodium
- Cas Number:
- 83833-37-8
- Molecular formula:
- C36H24CrN9Na2O9S
- IUPAC Name:
- hydroxylamine
- Test material form:
- solid: particulate/powder
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Ibm: GOHI; SPF-quality guinea pigs
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd. Wölferstrasse 4, CH-4414 Füllinsdorf/Switzerland
- Age at beginning of Acclimatization period: 6 - 8 weeks
- Body Weight at beginning of Acclimatization period: Control and Test Group 315 - 422 g; Pretest 334 - 420 g
- Identification: by unique cage number and corresponding ear tags.
- Randomization: randomly selected at time of delivery
- Housing: individually in Makrolon type-3 cages (size: 22x37x15 cm) with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz).
- Diet: pelleted standard Kliba 342, Batch nos. 61/94 (at delivery of the animals to 07-APR-1994) and 62/94 (from 08-APR-1994 to termination of test) guinea pig breeding/ maintenance diet ("Kliba", Klingentalmühle AG, CH-4303 Kaiseraugst), ad libitum
- Water: community tap water from Füllinsdorf, ad libitum. Once weekly additional supply
of ascorbic acid (1 g/1) via the drinking water.
- Acclimation period: one week for the control and test group under test conditions after health examination. No acclimatization for the animals of the pretest.
- Indication of any skin lesions: Only animals without any visual signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): between 20-23 °C
- Humidity (%): between 36.5 - 78 %
- Air changes (per hr): 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light (approx. 100 Lux) /12 hours dark
- Cleaning process: the duration of the cleaning process was approximately 30 minutes
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: For intradermal application: Freund's Complete Adjuvant, physiological saline and Bi-distilled water; for Epidermal application: Vaselinum album
- Concentration / amount:
- For intradermal application 0.1 ml of 1% of test article solution; for Epidermal application 25 % of test article in vaselinum album.
- Day(s)/duration:
- Intradermal Induction performed at Day 1; Epidermal induction performed at Day 8
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- 5 % of test item in vaselinum album
- Day(s)/duration:
- Test performed at Day 22
- No. of animals per dose:
- Number of animals for pretest: 6
Number of animals for main study: 30 - Details on study design:
- RANGE FINDING TESTS
INTRADERMAL INJECTIONS
Intradermal injections (0.1 ml/site) were made into the clipped flank of two guinea-pigs at concentrations of 5, 3 and 1% of the test article in bi-distilled water.
The resulting dermal reactions were assessed 24 hours later. For intradermal induction application a 1% test article dilution was selected.
EPIDERMAL APPLICATIONS
Both flanks of each of 4 guinea pigs were clipped and shaved just prior to the application. Thereafter 4 patches* of filter paper ( 2 x 2 cm) were saturated
with the test article at A = 25 % (this concentration used was found to be the most qualified to assure an optimum technical application procedure), B = 15 %,
C = 10 % and D = 5 % of the test article in vaselinum album and applied to the clipped and shaved flanks. The patches were covered by a strip of aluminum foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. This procedure ensured the intensive contact of the test article. The dressings were removed after an exposure period of 24 hours. Approximately 20.5 hours after removing of the dressing the application site was depilated with an approved depilatory cream (VEET Cream, Reckitt & Colman AG, CH-4123 Allschwil) to clean the application site from violet staining produced by the test article, so that possible erythema reactions were clearly visible at that time.
The depilatory was placed on the patch sites and surrounding areas, and left on for 3-5 minutes. It was then thoroughly washed off with a stream of warm, running water. The animals were then dried with a disposable towel, and returned to their cages.
The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema on a numerical basis according to Draize. The allocation of the different test dilutions to the sites (A,B,C,D) on the animals was alternated in order to minimize site to site variation in responsiveness.
For the epidermal induction the test article at 25% and for the challenge procedure the test article at 5% was selected.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal injections / performed on test day 1:
An area of dorsal skin from the scapular region (approximately 6 x 8 cm) was clipped free of hair. Three pairs of intradermal injections (0.1 ml/site) were made at the border of a 4 x 6 cm area in the clipped region as follows:
Test group: 1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) The test article, diluted to 1% with bi-distilled water.
3) The test article diluted to 1% by emulsion in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
Control Group: 1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) Bi-disti1 led water.
3)1:1 (w/w) mixture of bi-distilled water in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline
Epidermal applications / performed on test day 8:
One week after the injections, the scapular area (approximately 6 x 8 cm) was again clipped and shaved free of hair. A 2 x 4 cm patch of filter paper was
saturated with the test article (25 % in vaselinum album) and placed over the injection sites of the test animals. The patch was covered with aluminum foil
and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape. The dressings were left in place for approximately 48 hours. The epidermal application procedure described ensured intensive contact of the test article.
The guinea-pigs of the control group were treated as described above with vaselinum album only.
Reaction sites were assessed for erythema and oedema 24 and 48 hours after removal of the dressing, using the numerical grading system according to Draize.
B. CHALLENGE EXPOSURE
The test and control guinea-pigs were challenged two weeks after the epidermal induction application. The test and control guinea-pigs were treated in the same way.
Hair was clipped and shaved from a 5 x 5 cm area on the left and right flank of each guinea-pig just prior to the application. Two patches ( 2 x 2 cm) of filter
paper were saturated with the highest non-irritating concentration of 5 % (left flank) and the vehicle only (vaselinum album, applied to the right flank) using
the same method as for the epidermal application. The dressing were left in place for 24 hours.
21 hours after removing of the dressing the test sites were depilated with an approved depilatory cream (VEET Cream, Reckitt & Colman AG, CH-4123 Allschwil). The cream was placed on the patch sites for 3-5 minutes and then washed off with a stream of warm running water. When the application sites were clean and any stains from the test article removed the animals were dried with a disposable paper towel and returned to their cages.
24 and 48 hours after the removal of the dressing the application sites were assessed for erythema and oedema using the numerical scoring system according to Draize. - Positive control substance(s):
- yes
- Remarks:
- 4-AMINOBENZOIC ACID ETHYL ESTER 25 % IN MINERAL OIL
Results and discussion
- Positive control results:
- Moderate allergenic potency (grade 3) of the test article 4-AMINOBENZOIC ACID ETHYL ESTER.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 % in vaselinum album
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No toxic symptoms
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 % in vaselinum album
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No toxic symptoms
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- only vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- only vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Group:
- positive control
- Remarks on result:
- other: not reported
Any other information on results incl. tables
CONTROL GROUP
Injection site 1 (1:1 (v/v) mixture of Freund's Complete Adjuvant [FCA] and physiological saline)
The area around the injection site was oedematous and erythematous from test day 2 to 5 followed by necrosis, encrustation and exfoliation of the encrustation up to the termination of test (test day 27).
Injection site 2 (bi-distilled water)
The area around the injection site was oedematous and erythematous from test day 2 to 4.
Injection site 3 (1:1 (w/w) mixture of bi-distilled water in a 1:1 (v/v) mixture of FCA and physiological saline)
The reactions observed were identical to those obtained at injection site 1 with the mixture of FCA and physiological saline.
As the animals were bandaged with the semi-occlusive dressing no observations of the skin were possible on test day 9.
TEST GROUP
Injection site 1 (1:1 (v/v) mixture of Freund's Complete Adjuvant [FCA] and physiological saline)
The reactions observed were identical to those obtained in the control group with the mixture of FCA and physiological saline, at injection site 1.
Injection site 2 (1% solution of test article in bi-distilled water)
The area around the injection site was oedematous and violet discoloured from test day 2 to 4 and 2 to 8 respectively and became necrotic from test day 5 to 12 followed by encrustation and exfoliation of encrustation up to test day 27.
Injection site 3 (1% solution of test article in a 1:1 (v/v) mixture of of FCA and physiological saline)
The reactions observed were identical to those obtained at the injection site 2 with a 1% solution of test article in bi-distilled water. As the animals were bandaged with the semi-occlusive dressing no observations of the skin were possible on test day 9.
SKIN EFFECTS AFTER EPIDERMAL INDUCTION PERFORMED ON TEST DAY 8
CONTROL GROUP: No erythematous or oedematous reaction was observed in the animals treated with vaselinum album only. TEST GROUP: As the test article stained the skin violet, it was not possible to determine whether erythema was present. However, no oedema was observed. Violet discolouration was noted from test day 10 to 23.
SKIN EFFECTS AFTER THE CHALLENGE PERFORMED ON TEST DAY 22
CONTROL and TEST GROUP: No positive reactions were observed in the animals either when treated with vaselinum album alone or when treated with the test article at 5% in vaselinum album. Violet discolouration was noted from test day 23 (after removal of the dressing) to 25.
VIABILITY / MORTALITY / MACROSCOPIC FINDINGS
As there were no deaths during the course of the treatment period no necropsies were performed.
CLINICAL SIGNS, SYSTEMIC
No symptoms of systemic toxicity were observed in the animals.
BODY WEIGHTS
Two animals of the control group, 12 of the test, 2 of the intradermal pretest and all animals of the epidermal pretest lost weight during the acclimatization period. No loss of weight was noted during the treatment period.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- Non sensitising
- Executive summary:
Method
To assess the allergenic potential of the test substance in albino guinea pigs the Maximization-Test of B. Magnusson and A.M. Kligman (1969) was used, according to the OECD guideline 406. Ten males were used as control group and 20 males were used as test group.
The highest non-irritating test article concentration used for challenge application was 5% in vaselinum album.
Results
0% of the animals were positive at the 24- and 48-hour reading respectively after treatment with the highest non-irritating test substance concentration of 5% in vaselinum album. No toxic symptoms were evident in the guinea pigs of the control or test group. No deaths occurred.
Conclusion
Non sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.